Page 18 - Bharat Biotech

States shying away from administering Bharat Bio's Covid-19 vaccine Covaxin

A month on, 21 states and UTs have not administered a single shot of the vaccine

More Covid vaccine supplies lined up as India gets ready for Phase 3 drive

Bharat Bio may add 200 mn doses if needed; Serum to have 2.5 mn capacity by year-end

Chhattisgarh rejects Bharat Biotech vaccine approved without efficacy data

The developers and India's drug regulator, however, say the vaccine is safe and effective based on early and intermediate studies

A shot at recovery

Vaccine delivery needs to move beyond govt control

Top headlines: Setback for Amazon, India to appeal against Cairn verdict

On Monday, the central bank said it would buy bonds worth Rs 20,000 crore from the secondary markets on Wednesday. Read top news with Business Standard here

Serum Institute, Bharat Biotech ramp up Covid-19 vaccine export plan

Home-grown firms get new orders: 10 million for SII, 4.5 million for Bharat Bio

Bharat Biotech inks pact to commercialise Covid-19 vaccine Covaxin in US

Ocugen, a Nasdaq-listed firm, focuses on developing and commercialising gene therapies to cure blindness diseases

Supply order for Covishield was placed after drug regulator's nod: Govt

The Rajya Sabha was informed about this on Tuesday

SII, Bharat Biotech welcome enhanced focus on health in Budget 2021

Serum Institute of India and Bharat Biotech applauded the government's increased allocation for the healthcare sector and on providing Rs 35,000 crore towards Covid-19 vaccination in 2021-22 fiscal.

Bharat Biotech hails Rs 35,000 cr budget allocation for Covid vaccination

The indigenous Covid-19 vaccine Covaxin and Oxford's Covishield are being produced in the country

Bharat Biotech, SII seek to use Covid jab on those using blood thinners

"Both the companies have written to the DCGI regarding changing this point and that will happen very soon," Bhargava said

British firm GSK to move malaria vaccine production to Bharat Biotech

The agreement includes transfer of manufacturing of the protein part of the malaria vaccine

Bharat Biotech's Covaxin effective against Covid-19 UK strain: ICMR

The genome of the UK-variant has 17 mutations, eight of those were in the spike protein domain

GSK transfers malaria vaccine production to India's Bharat Biotech

The agreement includes transfer of manufacturing of the protein part of the vaccine

Bharat Biotech's Covaxin effective on UK strain of Covid-19: ICMR

In phase II clinical trial, the vaccine candidate showed noteworthy results with plaque reduction neutralization test

BS Reads: From deal-making to air lifting, how the world will be vaccinated

While mass airlifting of vaccines is yet to begin, global deal-making shows many interesting trends

Bharat Biotech's Covaxin has tolerable safety, says Lancet study

Sharing the interim findings, the paper said that the vaccine was well tolerated in all dose groups with no vaccine-related adverse events

No politics, followed scientific advice on Covid-19 vaccine, says PM Modi

In an interaction with beneficiaries from his constituency, PM assures both vaccines safe

13,000 volunteers given 2nd Covaxin dose in phase-3 trials: Bharat Biotech

Covaxin has received emergency use approval from India's drug regulator on a 'clinical trial mode'

Bharat Biotech first Indian Covid vaccine maker to get peer-reviewed data

There were no serious side effects in the participants enrolled for the phase 1 trials, according to the results published in The Lancet